Stockreport

Vertex in-licenses cell therapy technology for diabetes candidates [Seeking Alpha]

Vertex Pharmaceuticals Incorporated  (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
PDF the latter's cell manufacturing technology, C-Stem, targeting VRTX's cell therapies for type 1 diabetes. Under the collaboration, the duo will scale up the development [Read more]